Seegnal Inc.
TTSXV:SEGN0.20
CAD
-0.08
(-28.57%)
ISIN
CA81573E1060
CUSIP
81573E106
Return %
Stock
S&P 500
1Y
-58.76
14.20
3Y
-20.89
81.12
5Y
- -
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Quarterly Revenue
USD
•
in mil. unless spec.Quarterly Earnings Per Share
USD
•
in mil. unless spec.Quarterly Dividends Per Share
USD
•
in mil. unless spec.Company Description
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- Calgary Canada
- Website
- seegnal.com
- Similar Companies
- Business
- Seegnal Inc. is a digital healthcare technology company that provides a proprietary Software-as-a-Service (SaaS) clinical decision support platform designed to prevent adverse drug events, reduce alert fatigue, and optimize patient-specific medication management at the point of care. Founded in 2015 and headquartered in Ramat HaSharon, Israel, with corporate operations in Vancouver, British Columbia, Canada, the company operates primarily through its wholly owned subsidiary, Seegnal eHealth Ltd. The company delivers its core digital health solutions through its enterprise Prescription Operating System, which integrates directly with Electronic Medical Record (EMR) and Electronic Health Record (EHR) systems across inpatient, outpatient, long-term care, and pharmacy environments. Seegnal's product portfolio comprises: Seegnal DRP, an automated point-of-care clinical decision support engine that evaluates patient medical histories, clinical diagnoses, real-time laboratory values, vital signs, allergies, and pharmacogenetic data to identify and resolve drug-drug, drug-gene, drug-disease, drug-lab, and food-drug interactions as well as dosage anomalies; Seegnal Insights, an analytics and business intelligence platform that tracks clinical prescribing patterns, therapeutic outcomes, and organizational cost efficiencies; Seegnal Guard, an administrative governance and clinical policy management tool that enables healthcare systems to enforce evidence-based medication protocols, customize alerting criteria, and maintain formulary compliance; and MetricsGuard, a clinical decision support monitoring solution designed to quantify safety metric adherence and clinician engagement. In addition, the company provides EMR/EHR system integration, clinical workflow consulting, data configuration, and technical maintenance services. Seegnal serves health maintenance organizations, hospital networks, health systems, ambulatory care providers, and long-term care facilities across Israel, North America, the United Kingdom, the United Arab Emirates, and Poland. Recent corporate developments include the completion of a qualifying transaction and reverse takeover of Kalron Holdings Ltd. in August 2025, resulting in the company's public listing on the TSX Venture Exchange under the ticker symbol SEGN in September 2025; the appointment of Elad Bibi-Aviv as Chief Executive Officer in December 2025, alongside the transition of former CEO Eyal Schneid to General Manager of Seegnal eHealth Ltd.; the execution of a six-year enterprise contract extension with Maccabi Healthcare Services in September 2025; the launch of the company's first commercial pilot deployment with a long-term care provider in the United States in June 2026; and the completion of private placement financing tranches in August 2026 to accelerate platform development and commercial expansion across North American markets.